Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Shakado

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Hepatology International|March 2, 2019
Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter studyTatsuya Ide, Hironori Koga, Masahito Nakano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 3, 2012
Late-evening snack with branched-chain amino acids improves liver function after radiofrequency ablation for hepatocellular carcinomaDaisuke Morihara, Kaoru Iwata, Takayuki Hanano, et al.
Cancer Medicine|March 23, 2019
Predictors of hepatocellular carcinoma recurrence associated with the use of direct-acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort studyMasahito Nakano, Hironori Koga, Tatsuya Ide, et al.
Scientific Reports|January 28, 2022
Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019Masahito Nakano, Hiroshi Yatsuhashi, Shigemune Bekki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 3, 2010
Clinical features of Wilson disease: Analysis of 10 casesYasuaki Takeyama, Keiji Yokoyama, Kazuhide Takata, et al.
Targeted Oncology|October 22, 2022
Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching AnalysisTakashi Niizeki, Takayuki Tokunaga, Yuko Takami, et al.
Current Therapeutic Research, Clinical and Experimental|March 29, 2014
Postmarketing surveillance of rabeprazole in upper gastrointestinal peptic lesions in Japanese patients with coexisting hepatic disordersIsao Makino, Kimihide Nakamura, Yoichi Sato, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Hepatology International|March 2, 2019
Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter studyTatsuya Ide, Hironori Koga, Masahito Nakano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 3, 2012
Late-evening snack with branched-chain amino acids improves liver function after radiofrequency ablation for hepatocellular carcinomaDaisuke Morihara, Kaoru Iwata, Takayuki Hanano, et al.
Cancer Medicine|March 23, 2019
Predictors of hepatocellular carcinoma recurrence associated with the use of direct-acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort studyMasahito Nakano, Hironori Koga, Tatsuya Ide, et al.
Scientific Reports|January 28, 2022
Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019Masahito Nakano, Hiroshi Yatsuhashi, Shigemune Bekki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 3, 2010
Clinical features of Wilson disease: Analysis of 10 casesYasuaki Takeyama, Keiji Yokoyama, Kazuhide Takata, et al.
Targeted Oncology|October 22, 2022
Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching AnalysisTakashi Niizeki, Takayuki Tokunaga, Yuko Takami, et al.
Current Therapeutic Research, Clinical and Experimental|March 29, 2014
Postmarketing surveillance of rabeprazole in upper gastrointestinal peptic lesions in Japanese patients with coexisting hepatic disordersIsao Makino, Kimihide Nakamura, Yoichi Sato, et al.
Pageof 9